These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29506934)

  • 1. Risk Factors for Surgical Site Infection Following Lower Limb Arthroplasty: A Retrospective Cohort Analysis of 3932 Lower Limb Arthroplasty Procedures in a High Volume Arthroplasty Unit.
    Almustafa MA; Ewen AM; Deakin AH; Picard F; Clarke JV; Mahmood FF
    J Arthroplasty; 2018 Jun; 33(6):1861-1867. PubMed ID: 29506934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Operative Duration and Surgical Site Infection Risk in Hip and Knee Arthroplasty Procedures.
    Dicks KV; Baker AW; Durkin MJ; Anderson DJ; Moehring RW; Chen LF; Sexton DJ; Weber DJ; Lewis SS
    Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1431-6. PubMed ID: 26391277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
    Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
    J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Anesthetic Management on Surgical Site Infections in Patients Undergoing Total Knee or Total Hip Arthroplasty.
    Kopp SL; Berbari EF; Osmon DR; Schroeder DR; Hebl JR; Horlocker TT; Hanssen AD
    Anesth Analg; 2015 Nov; 121(5):1215-21. PubMed ID: 26484458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of surgical site infections following hip and knee arthroplasty: results of the ISChIA-GISIO study.
    Agodi A; Auxilia F; Barchitta M; Cristina ML; D'Alessandro D; Mura I; Nobile M; Pasquarella C; Gisio-SItI G;
    Ann Ig; 2017; 29(5):422-430. PubMed ID: 28715055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS).
    Song KH; Kim ES; Kim YK; Jin HY; Jeong SY; Kwak YG; Cho YK; Sung J; Lee YS; Oh HB; Kim TK; Koo KH; Kim EC; Kim JM; Choi TY; Kim HY; Choi HJ; Kim HB
    Infect Control Hosp Epidemiol; 2012 Nov; 33(11):1086-93. PubMed ID: 23041805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban Use for Thrombosis Prophylaxis Is Associated With Early Periprosthetic Joint Infection.
    Brimmo O; Glenn M; Klika AK; Murray TG; Molloy RM; Higuera CA
    J Arthroplasty; 2016 Jun; 31(6):1295-1298. PubMed ID: 26796776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Preoperative Surgical Site Infection Risk Score for Primary or Revision Knee and Hip Arthroplasty.
    Everhart JS; Andridge RR; Scharschmidt TJ; Mayerson JL; Glassman AH; Lemeshow S
    J Bone Joint Surg Am; 2016 Sep; 98(18):1522-32. PubMed ID: 27655979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
    Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
    J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Preoperative Screening Criteria Lowers Infection and Complication Rates Following Elective Total Hip Arthroplasty and Total Knee Arthroplasty in a Veteran Population.
    Nussenbaum FD; Rodriguez-Quintana D; Fish SM; Green DM; Cahill CW
    J Arthroplasty; 2018 Jan; 33(1):10-13. PubMed ID: 28838614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical site infection surveillance for elective primary total hip and knee arthroplasty in Winnipeg, Manitoba, Canada.
    Dyck M; Embil JM; Trepman E; Bohm E
    Am J Infect Control; 2019 Feb; 47(2):157-163. PubMed ID: 30274885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Operative Time a Predictor for Post-Operative Infection in Primary Total Knee Arthroplasty?
    Anis HK; Sodhi N; Klika AK; Mont MA; Barsoum WK; Higuera CA; Molloy RM
    J Arthroplasty; 2019 Jul; 34(7S):S331-S336. PubMed ID: 30545655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess cost associated with primary hip and knee joint arthroplasty surgical site infections: a driver to support investment in quality improvement strategies to reduce infection rates.
    Gow N; McGuinness C; Morris AJ; McLellan A; Morris JT; Roberts SA
    N Z Med J; 2016 Apr; 129(1432):51-8. PubMed ID: 27356252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Allogeneic Red Blood-Cell Transfusion Associated with Surgical Site Infection After Total Hip and Knee Arthroplasty.
    Everhart JS; Sojka JH; Mayerson JL; Glassman AH; Scharschmidt TJ
    J Bone Joint Surg Am; 2018 Feb; 100(4):288-294. PubMed ID: 29462032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers.
    Tandon T; Tadros BJ; Akehurst H; Avasthi A; Hill R; Rao M
    J Arthroplasty; 2017 Dec; 32(12):3711-3717. PubMed ID: 28739308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Readmissions after diagnosis of surgical site infection following knee and hip arthroplasty.
    Miletic KG; Taylor TN; Martin ET; Vaidya R; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):152-7. PubMed ID: 24442077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.
    Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P
    Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The projected burden of complex surgical site infections following hip and knee arthroplasties in adults in the United States, 2020 through 2030.
    Wolford HM; Hatfield KM; Paul P; Yi SH; Slayton RB
    Infect Control Hosp Epidemiol; 2018 Oct; 39(10):1189-1195. PubMed ID: 30157981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for surgical site infections in knee and hip arthroplasty patients.
    Simon S; Hollenbeck B
    Am J Infect Control; 2022 Feb; 50(2):214-216. PubMed ID: 34793889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Operative Time on Adverse Events Following Primary Total Joint Arthroplasty.
    Bohl DD; Ondeck NT; Darrith B; Hannon CP; Fillingham YA; Della Valle CJ
    J Arthroplasty; 2018 Jul; 33(7):2256-2262.e4. PubMed ID: 29551302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.